ProfileGDS4718 / 223011_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 97% 97% 97% 97% 98% 97% 96% 97% 97% 97% 97% 98% 97% 97% 97% 98% 97% 98% 97% 96% 97% 97% 97% 97% 97% 96% 98% 97% 97% 97% 97% 97% 97% 97% 98% 97% 97% 97% 97% 97% 97% 97% 97% 97% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]11.100697
GSM549102patient 115, normal, homogenized [OPG study]11.01797
GSM549104patient 119, normal, homogenized [OPG study]11.184797
GSM549108patient 138, normal, homogenized [OPG study]11.149697
GSM549119patient 077, normal, homogenized [OPG study]11.293898
GSM549133patient 032, cancer, homogenized [OPG study]10.855197
GSM549139patient 042, cancer, homogenized [OPG study]10.560396
GSM549099patient 107, normal, homogenized [OPG study]11.009497
GSM549109patient 139, normal, homogenized [OPG study]11.239597
GSM549110patient 046, normal, homogenized [OPG study]11.281897
GSM549114patient 063, normal, homogenized [OPG study]11.3697
GSM549122patient 082, normal, homogenized [OPG study]11.24598
GSM549134patient 033, cancer, homogenized [OPG study]11.035997
GSM549136patient 036, cancer, homogenized [OPG study]10.82597
GSM549140patient 044, cancer, homogenized [OPG study]10.680597
GSM549111patient 047, normal, homogenized [OPG study]11.337298
GSM549113patient 057, normal, homogenized [OPG study]11.36297
GSM549132patient 031, cancer, homogenized [OPG study]11.115498
GSM549137patient 038, cancer, homogenized [OPG study]10.814197
GSM549142patient 047, cancer, homogenized [OPG study]10.139596
GSM549100patient 110, normal, homogenized [OPG study]11.194197
GSM549107patient 135, normal, homogenized [OPG study]11.230997
GSM549115patient 068, normal, homogenized [OPG study]11.384397
GSM549116patient 072, normal, homogenized [OPG study]11.27297
GSM549120patient 078, normal, homogenized [OPG study]11.112197
GSM549131patient 030, cancer, homogenized [OPG study]10.684896
GSM549118patient 074, normal, homogenized [OPG study]11.285798
GSM549129patient 027, cancer, homogenized [OPG study]10.660797
GSM549123patient 088, normal, homogenized [OPG study]11.184997
GSM549124patient 006, cancer, homogenized [OPG study]10.761497
GSM549126patient 015, cancer, homogenized [OPG study]10.951497
GSM549128patient 025, cancer, homogenized [OPG study]10.776997
GSM549103patient 117, normal, homogenized [OPG study]10.940497
GSM549117patient 073, normal, homogenized [OPG study]11.29297
GSM549138patient 041, cancer, homogenized [OPG study]11.175798
GSM549141patient 045, cancer, homogenized [OPG study]10.718497
GSM549130patient 028, cancer, homogenized [OPG study]10.824797
GSM549101patient 111, normal, homogenized [OPG study]11.011197
GSM549105patient 128, normal, homogenized [OPG study]11.091397
GSM549106patient 134, normal, homogenized [OPG study]11.296597
GSM549112patient 048, normal, homogenized [OPG study]11.273697
GSM549125patient 011, cancer, homogenized [OPG study]10.859197
GSM549127patient 024, cancer, homogenized [OPG study]10.699897
GSM549135patient 035, cancer, homogenized [OPG study]10.761497